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lettuce and tobacco chloroplasts – oral administration 
protects against development of insulitis in non-obese 
diabetic mice
 
Tracey Ruhlman†, Raheleh Ahangari†, Andrew Devine, Mohtahsem Samsam and Henry Daniell*
 
University of Central Florida, Department of Molecular Biology and Microbiology, Biomolecular Science, Building #20, Orlando, FL 32816-2364, USA
 
Summary
 
Lettuce and tobacco chloroplast transgenic lines expressing the cholera toxin B subunit–
human proinsulin (CTB-Pins) fusion protein were generated. CTB-Pins accumulated up to 
~16% of total soluble protein (TSP) in tobacco and up to ~2.5% of TSP in lettuce. Eight 
milligrams of powdered tobacco leaf material expressing CTB-Pins or, as negative controls, 
CTB–green fluorescent protein (CTB-GFP) or interferon–GFP (IFN-GFP), or untransformed 
leaf, were administered orally, each week for 7 weeks, to 5-week-old female non-obese 
diabetic (NOD) mice. The pancreas of CTB-Pins-treated mice showed decreased infiltration 
of cells characteristic of lymphocytes (insulitis); insulin-producing 
 
β
 
-cells in the pancreatic 
islets of CTB-Pins-treated mice were significantly preserved, with lower blood or urine 
glucose levels, by contrast with the few 
 
β
 
-cells remaining in the pancreatic islets of the 
negative controls. Increased expression of immunosuppressive cytokines, such as 
interleukin-4 and interleukin-10 (IL-4 and IL-10), was observed in the pancreas of CTB-Pins-
treated NOD mice. Serum levels of immunoglobulin G1 (IgG1), but not IgG2a, were 
elevated in CTB-Pins-treated mice. Taken together, T-helper 2 (Th2) lymphocyte-mediated 
oral tolerance is a likely mechanism for the prevention of pancreatic insulitis and the 
preservation of insulin-producing 
 
β
 
-cells. This is the first report of expression of a therapeutic 
protein in transgenic chloroplasts of an edible crop. Transplastomic lettuce plants 
expressing CTB-Pins grew normally and transgenes were maternally inherited in T
 
1
 
 progeny. 
This opens up the possibility for the low-cost production and delivery of human therapeutic 
 
proteins, and a strategy for the treatment of various other autoimmune diseases.
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Introduction
 
Diabetes is a disease in which the body does not produce
or properly utilize insulin. Type 1 diabetes results from the
autoimmune destruction of insulin-producing cells. The major
destruction of 
 
β
 
-cells occurs predominantly from auto-
reactive T-cytotoxic cells (Nagata 
 
et al
 
., 1994) and T-helper-1
(Th1) cells (Ploix 
 
et al
 
., 1999) reactive to 
 
β
 
-cell autoantigens,
such as insulin. In 2002, the American Diabetes Association
estimated that 18.2 million people in the USA, or 6.3% of the
total population, had diabetes, with more than $120 billion
in treatment costs each year. In 2002, diabetes was the sixth
leading cause of death in the USA, contributing to 213 062
deaths. The only currently accepted form of treatment is
the administration of recombinant insulin, which serves to
temporarily replace the missing insulin in diabetic patients.
Therefore, it is essential to find a prevention and cure for this
debilitating disease.
Biopharmaceutical proteins expressed in plant cells should
reduce their cost of production. Transformation of plant
nuclear genomes has led to the expression of a number of
clinically important molecules in cell culture, organized tissue
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culture and whole plants (Rigano and Walmsley, 2005).
Common crop species, such as potatoes, rice and tomatoes,
have been engineered to express many therapeutic proteins
via the nuclear genomes of these plants (Ma 
 
et al
 
., 2003).
One of the major limitations has been the ability in these
systems to accumulate sufficient levels of protein, either for
purification or for oral delivery in minimally processed plant
tissues. The integration of transgenes via the nuclear genome
may have other disadvantages, including transgene con-
tainment, gene silencing and position effect. The chloroplast
genetic engineering approach can overcome concerns about
transgene containment (Daniell, 2002), gene silencing
and position effect (De Cosa 
 
et al
 
., 2001; Lee 
 
et al
 
., 2003),
pleiotropic effects (Daniell 
 
et al
 
., 2001; Lee 
 
et al
 
., 2003) and the
presence of antibiotic-resistant genes or vector sequences
in transformed genomes (Daniell 
 
et al
 
., 2004a,b, 2005a,b;
Grevich and Daniell, 2005). Multigene engineering is possible
with chloroplast transformation because of its prokaryotic
nature (De Cosa 
 
et al
 
., 2001; Quesada-Vargas 
 
et al
 
., 2005).
Several vaccine antigens have been expressed via the
chloroplast genome against bacterial, viral and protozoan
pathogens, including the cholera toxin B subunit (CTB)
(Daniell 
 
et al
 
., 2001), anthrax protective antigen (Watson
 
et al
 
., 2004; Koya 
 
et al
 
., 2005), the C-terminus of 
 
Clostridium
tetani
 
 (Tregoning 
 
et al
 
. 2003), the 2L21 peptide from the
canine parvovirus (Molina 
 
et al
 
., 2004), rotavirus VP6 protein
(Birch-Machin 
 
et al
 
., 2004) and the GAL/GALNAc lectin of
 
Entamoeba histolytica
 
 (Chebolu and Daniell, 2007).
In addition to their use for the hyper-expression of vaccine
antigens, transgenic chloroplasts have been employed in our
laboratory for the production of valuable therapeutic proteins,
such as human elastin-derived polymers for various biomedical
applications (Guda 
 
et al
 
., 2000), human serum albumin
(Fernandez-San Millan 
 
et al
 
., 2003), magainin (a broad-
spectrum topical agent, systemic antibiotic, wound healing
stimulant and potential anticancer agent) (DeGray 
 
et al
 
., 2001),
various interferon-
 
α
 
 (IFN-
 
α
 
) proteins (Daniell 
 
et al
 
., 2004a,
2005a; Arlen 
 
et al
 
., 2007) and insulin-like growth factor 1
(Daniell 
 
et al
 
., 2005a). Several other laboratories have
expressed other therapeutic proteins, including human soma-
totropin (Staub 
 
et al
 
., 2000) and IFN-
 
γ
 
–
 
β
 
-glucuronidase
(IFN-
 
γ
 
-GUS) fusion proteins (Leelavathi and Reddy, 2003), in
transgenic chloroplasts. The successful expression and assembly
of complex multisubunit proteins, exemplified above, demon-
strate that chloroplasts contain the machinery that allows for
correct folding and disulphide bond formation, resulting in
fully functional proteins (Kamarajugadda and Daniell, 2006).
The oral delivery of biopharmaceutical proteins expressed
in plant cells should reduce the costs associated with
purification, processing, cold storage, transportation and
delivery. However, poor intestinal absorption of intact proteins
has been a major challenge. To overcome this limitation, we
investigated the concept of receptor-mediated oral delivery
of transgenic proteins (Limaye 
 
et al
 
., 2006). The B subunit of
the toxin from 
 
Vibrio cholerae
 
 (CTB) is recognized as one of
the most potent mucosal adjuvants (Holmgren 
 
et al
 
., 2005).
CTB and green fluorescent protein (CTB-GFP), separated by
a furin cleavage site, were expressed via the tobacco
chloroplast genome. Following the oral administration of
CTB-GFP-expressing leaf material to mice, GFP was observed
in the mice intestinal mucosa, liver and spleen in fluorescence
and immunohistochemical studies, whereas CTB remained in
the intestinal cell (Limaye 
 
et al
 
., 2006). This report of receptor-
mediated oral delivery of a foreign protein into the circulatory
system brings the oral delivery of human therapeutic proteins
one step closer to realization.
Clearly, there are advantages to plastid expression; how-
ever, in terms of minimally processed orally delivered vegeta-
tive biomass, there is a need to move beyond tobacco and
to focus on edible crop plant systems. The transformation of
plastids in non-green tissue has been achieved, especially in
edible parts of carrot, providing access to several new poten-
tial platforms for pharmaceutical production (Kumar 
 
et al
 
.,
2004a,b; Daniell 
 
et al
 
., 2005b). For this study, 
 
Lactuca sativa
 
(lettuce) was chosen for investigation. Although, recently,
two laboratories have reported stable plastid transformation
in lettuce, the expression of therapeutic proteins has been
unsuccessful (Lelivelt 
 
et al
 
., 2005; Kanamoto 
 
et al
 
., 2006).
The non-obese diabetic (NOD) mouse is a useful animal
model for research in human diabetes (Homann 
 
et al
 
., 1999).
These mice show signs of insulitis as a result of lymphocytic
infiltration of the endocrine part of the pancreas, which leads
to decreased production of insulin and increased blood sugar,
with its consequent pathologies. In this study, the effect of
the oral administration of tobacco chloroplast-derived pro-
insulin conjugated to CTB (CTB-Pins fusion) for the induction
of oral tolerance towards insulin was examined. The first
report of the accumulation of a valuable therapeutic protein,
the CTB-Pins fusion, in lettuce chloroplasts is also presented.
 
Results
 
Vector construction of pLD-5
 
′
 
UTR-CTB-Pins
 
The 
 
CTB-Pins
 
 fusion gene was inserted into the chloroplast
transformation vector pLD-ctv as described previously (Daniell
 
et al
 
., 2004b). The 5CP construct was expressed under the
control of the 
 
psb
 
A 5
 
′
 
 untranslated region (UTR)/promoter in
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order to achieve hyper-expression, as demonstrated previously
for other transgenes (Daniell 
 
et al
 
., 2004b). To prevent steric
hindrance, a glycine–proline–glycine–proline (GPGP) hinge
was introduced between the fusion elements (Arakawa
 
et al
 
., 1998). The 3
 
′
 
 UTR located at the 3
 
′
 
 end of the intro-
duced gene confers transcript stability (Stern and Gruissem,
1987; Figure 1a).
The 
 
L. sativa
 
 long flanking plastid transformation vector
(pLS-LF, Figure 2a) was constructed using primers derived
from regions of known conservation in the 
 
Nicotiana tabacum
 
plastome to amplify cognate sequences from the 
 
L. sativa
 
plastome. The full-length genes for plastid 
 
trnl
 
 (Ile) (1020 bp)
and 
 
trnA
 
 (Ala) (887 bp) were amplified and cloned. The
unique 
 
Pvu
 
II site was used to insert transformation cassettes
into the intergenic spacer region between the tRNAs. Long
flanking sequences encoding portions of the 16S (810 bp)
and 23S (974 bp) ribosomal RNA subunits were included to
enhance homologous recombination between the vector
and the host plastome. The tobacco native plastid ribosomal
operon promoter (P
 
rrn
 
) and 3
 
′
 
 UTRs (
 
psbA
 
 and 
 
rps
 
16) were
used to drive the expression of AadA from the GGAGG
ribosome binding site and 
 
CTB-Pins
 
 from the 5
 
′
 
-translation
control element of bacteriophage T7 gene10 (Figure 2a).
Following the assembly of pLS-LF-CTB-Pins, plasmids were
isolated from spectinomycin-resistant cultures and correct
orientation was confirmed by 
 
Sac
 
I digest.
 
Transformation and regeneration of transplastomic 
plants
 
The bombardment of 10 tobacco leaves resulted in 56 in-
dependent transformation events, 40 of which were subjected
to three rounds of selection, two on regeneration medium of
plants (RMOP) and one on Murashige and Skoog medium
without hormones (MS0) medium containing 500 mg/L
spectinomycin. Integration of the transgene cassette was
confirmed by polymerase chain reaction (PCR).
The bombardment of 60 lettuce leaves resulted in two
independent transformation events (lines L100 and L101),
identified as green shoots arising directly from completely
bleached tissue on lettuce regeneration (LR) medium con-
taining 50 mg/L spectinomycin (Figure 2d). It should be noted
that no callus was formed prior to the initiation of shoots
from leaf explants. Following an additional round of selective
regeneration, a progenitor for each line was rooted in MS
medium containing spectinomycin (50 mg/L) and multiplied
by clonal propagation. Clones were transferred to soil
(Figure 3a) and moved to the glasshouse, where they matured
(Figure 3b), bolted and produced normal panicles (Figure 3c)
and inflorescences with disc flowers (Figure 3d). Pappus-
bearing achenes (seeds) were harvested. Lettuce seeds (T
 
1
 
)
were sterilized and germinated on spectinomycin-containing
medium (50 mg/L) together with wild-type (WT) seeds
(Figure 3e). T
 
1
 
 seeds germinated and grew into uniformly
green plants (Figure 3f). The absence of Mendelian seg-
regation of transgenes indicated that they were maternally
inherited to progeny. Most WT seeds failed to germinate
on spectinomycin-containing medium. Of the 30 WT seeds
plated, six reached radicle emergence, but hypocotyl emer-
gence was not observed and none developed into seedlings.
 
Analysis of the transgenic chloroplast genome confirms 
homoplasmy
 
Chloroplast transgenic lines were examined by Southern
analysis in order to confirm site-specific integration and to
determine whether they were homoplasmic or heteroplasmic.
Homoplasmy is achieved when all the copies of the genome
within the chloroplast have stably integrated transgenes. For
tobacco, the gene-specific probe (
 
CTB-Pins
 
) taken from the
Figure 1 Southern analysis of cholera toxin B subunit–human proinsulin 
(CTB-Pins) tobacco transformants. (a) Schematic representation of 
expected results in Southern analysis. Full lines indicate expected 
fragment for wild-type (4.2 kb) and transformed (6.35 kb) genomes; 
broken line indicates the probe hybridization sites. (b) Southern analysis 
of second regenerants. 5CP lines 13, 14, M, O and P were derived from 
independent transformation events; WT, wild-type.
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Figure 2 Regeneration and Southern analysis of cholera toxin B subunit–human proinsulin (CTB-Pins) lettuce transformants. (a, b) Schematic diagrams 
of lettuce transformation vector and integration cassette, integration site and resulting transplastome. Full lines indicate the sizes of the integration 
cassette (2.4 kb) and expected fragments for the wild-type (3.75 kb) and transformed (6.15 kb) genomes in Southern analysis; broken line indicates the 
probe hybridization sites. (c) Southern analysis of second regenerants. L100 and L101, independent transplastomic lines; WT, wild-type. (d) Primary 
regeneration in lettuce without formation of callus.
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pLD-5CP vector by 
 
Mfe
 
I/
 
Not
 
I digestion hybridized to a single
6.4-kb fragment in transgenics, but not to any WT plant DNA
fragment (data not shown). The flanking sequence probe
contained regions of the 
 
trn
 
I and 
 
trn
 
A genes. In most of the
transgenic lines, only the 6.4-kb fragment was seen when
hybridized with this probe (Figure 1b), indicating that homo-
plasmy was achieved within limits of detection by Southern blot.
For the confirmation of homoplasmy in lettuce transgenic
lines, labelled flanking sequence probe (1.3 kb) was hybridized
to 
 
Bgl
 
II-digested genomic DNA. The hybridization pattern
showed only the expected 3.75-kb fragment in the WT
sample and only the expected 6.15-kb fragment in lettuce
transformants after second regeneration (Figure 2c). Southern
blotting was also carried out with genomic DNA samples
from the primary regenerants. Although the L100 line
demonstrated heteroplasmy, with both WT and transformed
fragments hybridizing with the probe, primary regenerant
L101 appeared to be homoplasmic (data not shown).
Previous studies with tobacco have demonstrated that
homoplasmy can indeed be achieved in the first round of
selection (Guda 
 
et al
 
., 2000), because the flanking sequence
contained an origin of replication (thereby providing more
templates for integration). As the lettuce transformation
vector includes full-length lettuce 
 
trn
 
I gene, which probably
contains 
 
Ori
 
A, it is not unreasonable to find this phenomenon
in lettuce plastid transformants as well.
 
CTB-Pins accumulation and pentamer assembly in 
transgenic chloroplasts
 
Immunoblots probed with the human proinsulin monoclonal
antibody showed the presence of an ~22-kDa fusion protein
in the chloroplast transgenic lines. The formation of dimers,
trimers, tetramers and pentamers of the CTB-Pins fusion
protein was also observed (Figure 4a,b). A similar banding
pattern was observed by immunodetection with CTB
polyclonal antibody (Figure 4c). Quantification of the fusion
protein on western blots was performed by comparing plant
samples with known quantities of purified CTB and analysing
them by spot densitometry. Linearity of the standard curve
was achieved using 25, 50 and 100 ng of CTB, facilitating the
estimation of CTB expression in samples in the same blot
(Figure 4d). The three tobacco transgenic lines were found to
contain up to 178.2, 126.7 and 139.1 
 
µ
 
g of CTB-Pins per
100 mg of leaf tissue, i.e. approximately 16% of total soluble
protein (TSP) (Figure 4e). Such variation could be the result
of the use of fresh vs. frozen plant material for these assays,
or differences in sample preparation or growth conditions.
Lettuce lines L100 and L101 accumulated up to 13.6 and
15.3 
 
µ
 
g per 100 mg of leaf tissue, respectively, approximately
2.02% and 2.43% of TSP. The GM
 
1
 
 binding assay demon-
strated that pentameric structures of CTB-Pins were formed
(Figure 4f). This assay confirmed the correct folding and
disulphide bond formation of CTB pentamers within trans-
genic chloroplasts, as only the pentameric structure of CTB
has the ability to bind to the GM
 
1
 
 receptor (Merritt 
 
et al
 
., 1994).
Despite a number of experimental approaches, we were
unable to establish the expression level of CTB-Pins in tobacco
or lettuce plants via enzyme-linked immunosorbent assay
(ELISA). The highest absorbance values were observed in the
GM
 
1
 
 binding assay from samples extracted under reducing
conditions. Although we would expect reduction of dis-
ulphide bonds to abrogate the ability of our fusion protein to
associate with the plate-bound receptor in pentameric form
(Ludwig 
 
et al
 
., 1985; Dertzbaugh and Cox, 1998), plant
extracts prepared in western extraction buffer [14 m
 
M
 
 (beta)-
mercaptoethanol (
 
β
 
-me)] or with a molar excess of dithiothreitol
(0.5 
 
M
 
 DTT) clearly facilitated GM
 
1
 
 binding, as indicated by
elevated absorbance readings. The potential for protein aggre-
gation to occur in plant extracts increases with the concentration
of the protein in question. Together, CTB monomers and the
proinsulin molecule contain several cysteine residues through
which disulphide bonds form, both intramolecularly and inter-
molecularly. We believe that the aggregation of the CTB-Pins
fusion confounded our efforts to execute quantitative ELISAs.
 
Lymphocytic infiltration of the endocrine part of the 
pancreas (insulitis)
 
Insulitis is characterized by lymphocytic infiltration of the
pancreatic islets, which leads to their destruction, including
the insulin-producing 
 
β
 
-cells. The pancreases were collected
from 12-week-old NOD mice from the different treatment
groups to assess the degree of insulitis.
To quantify and compare insulitis between the treatment
groups, representative sections were prepared and cellular
infiltration was scored in a blind manner. Fifty sections per
animal were analysed. The average score indicated that the
pancreases from NOD mice treated with CTB-Pins showed
minimal cellular infiltration, and this cellular infiltration was
significantly less than in all the other treatment groups
(Figure 5a–c).
Preservation of insulin-producing β-cells following oral 
delivery of CTB-Pins
We next determined whether the remaining β-cells in the
pancreases of the different treatment groups were apoptotic.
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Because cellular infiltration can lead to apoptosis, this can be
used as a hallmark to study type 1 diabetes (Riedl and Shi,
2004). It was found that the β-cells from NOD mice treated
with CTB-Pins rarely expressed caspase-3, suggesting that
apoptosis was prevented in these cells. In the other experi-
mental groups, even the very few remaining insulin-producing
β-cells expressed activated caspase-3, suggesting that they
were undergoing apoptosis (Figure 6).
Figure 3 Production of transplastomic Latuca sativa and confirmation of maternal inheritance. (a) Lettuce plants propagated by rooting of nodal cuttings 
were transferred to soil in the glasshouse. Plants matured with no apparent aberrant phenotype (b) and produced normal inflorescences (c). Flowers 
heads opened (d), and seeds were harvested. T1 seeds were plated on half-strength Murashige and Skoog (MS) medium containing 50 mg/L 
spectinomycin, together with wild-type seed (e). T1 plants flourished and were transferred to the glasshouse (f).
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Induction of T-helper 2 (Th2) response and production 
of immunosuppressive cytokines
Oral administration of CTB-Pins to NOD mice led to an
increased recruitment of immunosuppressive cytokine-
producing cells (lymphocytes) to the pancreas. A large
number of interleukin-4 (IL-4) and interleukin-10 (IL-10)-
producing cells were seen proximal to the pancreatic islets,
which were recruited through the circulation. This process
was supported by significant perivascular migration of
Figure 4 Protein analyses. Western blots prepared from wild-type (WT) and transplastomic lettuce and tobacco were probed with human proinsulin 
monoclonal antibody. (a) Total protein (~20 µg) extracted from lettuce leaves was loaded into wells for each sample. In lane 6, L101-5, ~10 µg of total 
soluble protein (TSP) was loaded. (b) Total protein (~10 µg) extracted from tobacco leaves was loaded into wells. (c) Cholera toxin B subunit–human 
proinsulin (CTB-Pins) in plant samples was detected by polyclonal anti-CTB and quantified by comparison with known quantities of CTB standard. Lanes 
1–3, bacterial CTB (25, 50, 100 ng). Lanes 4–6, transplastomic tobacco lines 5CP-13, 5CP-14, 5CP-M (~6 µg of TSP in each lane). Lanes 7 and 8, 
transplastomic lettuce lines L-100 and L-101 (~36 µg TSP in each lane). (d) Plot of integrated density values (IDVs) for quantitative analysis from standard 
curve. Broken line, data points; full line, trend line. (e) Estimation of CTB-Pins in tobacco and lettuce leaves using spot densitometry CTB immunoblots. 
(f) Tobacco and lettuce transformants were assayed for GM1 binding. 5CP, CTB-Pins tobacco; L101 and L101, CTB-Pins lettuce; BSA, negative control 
(bovine serum albumin).
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Figure 5 (a) Histochemical staining of 
pancreatic sections. (i) Haematoxylin and eosin 
staining of a section of the pancreas (showing 
an islet, isl) of a mouse receiving cholera toxin B 
subunit–human proinsulin (CTB-Pins) for 
7 weeks (n = 7); scale bar, 50 µm. Lymphocytes 
are seen outside the islet (arrow). (ii) Arrows 
indicate the borders of an islet in the pancreas of 
a mouse receiving CTB–green fluorescent 
protein (CTB-GFP) (n = 5; control group). Blue 
dots show lymphocytic infiltration of the islet. 
(iii) A large islet with severe lymphocytic 
infiltration in a mouse receiving untransformed 
plant leaf material (UN-Tr; n = 3). (iv) Severe 
lymphocytic infiltration in a mouse receiving 
interferon–GFP (IFN-GFP) (n = 5). (b) Scoring (S) 
of the degree of insulitis according to the 
severity of the lymphocytic infiltration of the 
pancreatic Langerhans islets. Score 1, no or 
pre-islet infiltration; 2, minimal infiltration; 
3, moderate infiltration; 4, severe infiltration; 
5, more than 80% of the islets infiltrated. 
All sections were scored in a blind manner. 
(c) Graphic representation of insulitis scoring in 
untransformed, IFN-GFP, CTB-GFP and CTB-Pins 
plant-treated groups; bars represent standard 
deviation (*P < 0.05). n indicates the number of 
animals in each treatment group.
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IL-4- and IL-10-expressing cells in the pancreases of CTB-
Pins-treated NOD mice (Figure 7a,b).
Serum and intestinal immunoglobulin (Ig) levels 
following oral delivery of CTB-Pins
Serum and intestinal mucosal Ig levels were determined by
ELISA using CTB as the capture antigen. Serum levels of IgG1
increased in NOD mice treated with CTB-Pins-expressing
plant leaf material, relative to the control groups. Low serum
IgG2a and mucosal IgA levels against CTB were observed in
NOD mice treated with untransformed plant leaf material or
plants expressing IFN-GFP or CTB-Pins (Figure 8a).
Blood and urine glucose levels of NOD mice treated 
with CTB-Pins
Blood and urine glucose levels of the treated NOD mice were
measured twice, at weeks 6 and 7 of treatment (11- and 12-
week-old mice). The blood glucose values of all groups in the
study at both time points tested were below 200 mg/dL,
and therefore were not considered as diabetic. This was not
unforeseen, as NOD mice typically do not develop high blood
glucose until 12–15 weeks of age (Arakawa et al., 1998).
Although, at week 11, the CTB-Pins-treated group showed
a blood glucose level as high as that of the control animals,
interestingly, at week 12, the CTB-Pins-treated animals
showed a significantly lower blood glucose level than that of
the control groups. Urine glucose values were also lower in
the CTB-Pins-treated group (Figure 8b).
Discussion
Oral tolerance, induced by the feeding of autoantigens, has
been applied successfully as a therapeutic tool in experimental
models of autoimmune diseases (Strobel and Mowat, 1998).
The basic mechanism of oral tolerance in humans is currently
a work in progress, and oral antigen administration regimens
have resulted in limited success when applied to patients
(Garside et al., 1999; Chaillous et al., 2000; Pozzilli et al.,
2000). A possible explanation for this limited success may
be that the doses of antigens administered orally to humans
were low compared with those delivered to mice, considering
the surface area of the intestinal absorptive epithelium
(Pozzilli and Cavallo, 2000). In this case, CTB may serve as the
necessary cofactor required to overcome the inefficient
presentation of insulin to mucosal T-cells, resulting from
the limited transport of native insulin across the epithelial
layer. In order for oral tolerance to become a realistic therapy
for human autoimmune diseases, adjuvants that possess
the ability to enhance the tolerogenic potential of orally
delivered antigens need to be identified. The coupling of
Figure 6 Assessment of insulin production and apoptosis in pancreatic β-cells. (a) Insulin immunoreactivity in Langerhans islets of a mouse receiving 
cholera toxin B subunit–human proinsulin (CTB-Pins). (b) Caspase-3 immunostaining in the same section is shown in the red channel. (c) Merged picture 
of (a) and (b). (d) A view of the pancreas showing the remnant of a large Langerhans islet in a mouse receiving untransformed plant leaf material. 
(e) Caspase-3 immunoreactivity in the same section taken in the red channel. (f) Merged picture of (d) and (e).
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Figure 7 Immunostaining for cytokine production. (a) Interleukin-10 (IL-10) immunoreactivity in the pancreas of three mice administered untransformed 
plant leaf material (i–iii). Blood vessels (BV) and Langerhans islets (isl) are indicated. (iv–vi) Islets of mice receiving cholera toxin B subunit–human proinsulin 
(CTB-Pins). Small arrows indicate perivascular infiltration of IL-10-expressing lymphocytes. Large arrows indicate IL-10-positive lymphocytes inside or 
around the islets. (b) Interleukin-4 (IL-4) immunoreactivity in the pancreas of mice receiving interferon–green fluorescent protein (IFN-GFP), CTB-GFP or 
CTB-Pins plant leaf material. Small arrows indicate position of the islets.
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autoantigens – in this case, proinsulin – to non-toxic CTB
dramatically increases their tolerogenic potential (Sun et al.,
1994; Bergerot et al., 1997; Arakawa et al., 1998). This effect
is mediated by the ability of CTB to act as a transmucosal
carrier, although CTB may have a direct affect on the immune
system (Burkart et al., 1999; Li and Fox, 1999). The current
primary limitation in advancing this concept in clinical trials
is the low levels of expression in transgenic plants (Bergerot
et al., 1997). This limitation can be overcome by the hyper-
expression of the CTB-Pins fusion protein in transgenic
chloroplasts.
Previous studies expressing the CTB-Pins fusion protein in
plants have been performed in potato (Arakawa et al., 1998).
The expression level in nuclear transgenic potato tubers was
0.1% of TSP. This low expression level required the feeding
of NOD mice with large amounts of fresh potatoes. In the
present study, the CTB-Pins fusion protein accumulated
in transplastomic tobacco to up to ~16% of TSP, 160-fold
greater than that achieved in nuclear transgenic potatoes.
NOD mice were given 8 mg of CTB-Pins tobacco leaf tissue
(containing ~14 µg of the fusion protein) per week by gavage;
this represents a 375-fold decrease in the amount of plant
tissue administered compared with the 3 g per week used
previously (Arakawa et al., 1998). The use of these small
concentrated doses reduces the possibility of the potential
confounding effects of leaf tissue, and eliminates the need
to process or purify large quantities of plant material. Hyper-
expression of CTB-Pins in plant plastids should make this
fusion protein abundantly available for animal studies or
human clinical trials.
Although lower levels of CTB-Pins accumulation were
observed in transplastomic lettuce when compared with
tobacco (approximately sixfold less in lettuce), the average
value determined for lettuce (~1.8% of TSP) represents a
level of protein sufficient to proceed with animal or preclinical
studies. For example, in this study, using tobacco, we delivered
approximately 14 µg of CTB-Pins to NOD mice; a comparable
dose could be derived from 100 mg of fresh lettuce leaf,
Figure 8 Determination of immunoglobulin (Ig) and glucose levels. (a) Serum levels of IgA, IgG2a and IgG1 in non-obese diabetic (NOD) mice receiving 
cholera toxin B subunit–human proinsulin (CTB-Pins)-expressing plant leaf material. Control groups receiving untransformed plant material (Un-Tr) or 
interferon–green fluorescent protein (IFN-GFP)-expressing leaf material are also shown. (b) Blood and urine glucose levels in various groups of NOD mice 
after oral administration of CTB-Pins (6 weeks post-treatment). Un-Tr, n = 1; IFN-GFP, n = 1; CTB-GFP, n = 2; CTB-Pins, n = 2. Using Student’s t-test, 
P value is less than 0.05. Bars, standard deviation. n indicates the number of animals in each treatment group.
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a feasible quantity for weekly oral delivery. The difference
observed between tobacco and lettuce may be attributed,
in part, to the 5′ regulatory elements used in our study.
Tobacco expression of CTB-Pins is driven by the endogenous
psbA 5′ UTR, whereas lettuce expression is regulated by the
inclusion of the translational control region of bacteriophage
T7 gene 10. Previous studies have demonstrated that the
level of foreign protein accumulation is lower when these
translation elements are used to drive expression of the same
gene, with psbA 5′ UTR being more efficient (Dhingra et al.,
2004). In addition, intrinsic variation in the nature of the
leaves from tobacco and lettuce may influence the accumu-
lation of foreign protein expressed in chloroplasts. We are
developing new transformation constructs for lettuce for
CTB-Pins expression which will employ lettuce endogenous
translation elements, such as psbA 5′ UTR, to further increase
the level of expression.
The oral administration of self-antigens, such as insulin,
leads to their uptake by gut-associated lymphoid tissue
(GALT), including intestinal mucosal M-cells, which pass the
antigen to underlying antigen-presenting cells (Limaye et al.,
2006). This leads to the activation of T-cells and the induction
of a Th2 cell response, which is characterized by the up-
regulation of immunosuppressive cytokines (such as IL-10
and IL-4) and serum antibodies (such as IgG1, but not IgG2a)
(Salmond et al., 2002; Faria and Weiner, 2005). No significant
increase in mucosal IgA was seen in our study in CTB-Pins-
treated mice vs. the control groups. CTB-Pins-treated animals
showed very high levels of IgG1, but not IgG2a, whereas the
control groups showed no variation (Figure 8a). The serum
IgG1 values of CTB-Pins-treated animals confirm the activated
Th2 response, which is also supported by the histology,
with less lymphocytic infiltration, the up-regulation of
immunosuppressive cytokine levels in the tissues, and the
trend in the blood and urine glucose levels (which were higher
in the control groups than in the CTB-Pins-treated group).
The presence of CTB in the intestine ensures effective
receptor-mediated oral delivery of intact plant-derived fusion
protein across the intestinal mucosa via the binding of CTB
to the GM1 ganglioside receptor and uptake by intestinal
M-cells and enterocytes.
Taken together, the data presented here suggest that the
suppression of insulitis is mediated by regulatory Th2 cells.
As T-cell regulation plays a major role in mucosal immunity,
the oral administration of an autoantigen can be used to treat
autoimmune diseases in animal models by generating active
T-cell suppression. Several autoimmune diseases and their
antigens are known: multiple sclerosis (myelin basic protein
and proteolipid protein), arthritis (type II collagen), uveitis
(S-antigen and interphotoreceptor retinoid binding protein),
myasthenia gravis (acetylcholine receptor) and thyroiditis
(thyroglobin) (Hafler and Weiner, 1997). In the USA, 5.5 million
people suffer from psoriasis, 3 million from Graves’ disease,
2.5 million from rheumatoid arthritis, 2–5 million from vitiligo,
3.5 million from thyroiditis, 1–4 million from Sjogren’s syn-
drome, 0.5 million from Crohn’s disease and multiple sclerosis,
370 000 from type 1 diabetes, etc. This study opens up the
possibility for new investigations on autoimmune diseases.
Five-week-old mice were used in this study to demonstrate
the alleviation of symptomatic pancreatic insulitis and the
preservation of insulin-producing β-cells, a condition that
mimics human type 1 diabetes. Based on the success of the
concept in older mice (Harrison et al., 1996), this strategy is
likely to work not only prior to the onset of diabetes, but also
at later stages of this autoimmune disease, and this will be
explored in future experiments. One previous human clinical
study on the oral delivery of insulin was unsuccessful (Skyler
et al., 2005), because insulin was not protected from digestive
enzymes and acid hydrolysis. In our study, however, insulin
was protected by bioencapsulation within plant cells. On the
basis of the results obtained in this study, human clinical trials
have been initiated.
Experimental procedures
Vector construction
The human proinsulin gene was synthesized according to Prodro-
mou and Pearl (1992). The PCR product was then cloned into the
PCR 2.1 vector and the sequence was verified. The psbA promoter
and 5′ UTR were amplified from the tobacco chloroplast genome,
followed by subcloning and sequence verification. The promoter-
5′UTR fragment was then spliced together with CTB and human
proinsulin by overlap extension (Horton et al., 1989). The construct
containing 5′UTR-CTB, a GPGP hinge region (introduced by muta-
genesis to allow for the correct folding of each protein by reducing
steric hindrance) and human proinsulin was designated as 5CP.
Following SalI/NotI digestion, the fusion gene was ligated into the
pLD-ctv chloroplast transformation vector (Daniell et al., 1998, 2004b).
The pUC-based L. sativa long flanking plasmid (pLS-LF; Figure 2a)
was constructed to integrate foreign genes into the intergenic spacer
region between the trnI (Ile) and trnA (Ala) genes of the plastid
genome inverted repeat region. Oligonucleotide primers were
derived from regions of known conservation in the N. tabacum
plastome, and carried end modifications for restriction enzyme sites
for use in vector assembly. The full-length genes for plastid trnl (Ile)
(position 101 979–102 998) and trnA (Ala) (position 103 063–103 949)
were amplified and ligated into the pUC19 backbone. A unique PvuII
recognition site (position 103 002) between the two sequences
facilitated the insertion of transformation cassettes. Long flanking
sequences encoding the 3′ end of the 16S (100 876–101 979; 810 bp)
and 5′ end of the 23S (104 102–105 075; 974 bp) ribosomal RNA
subunits were amplified and cloned in kind. The numeric values
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correspond to the positions in the L. sativa plastome (NC_007578).
The transformation cassette (Figure 2a) was assembled in pZERO
(Invitrogen, Carlsbad, CA, USA) and included the following
published tobacco plastid regulatory sequence elements: ribosomal
operon promoter (Prrn), rps16 and psbA-3′ UTRs. The 5′ translation
control region of bacteriophage T7 gene 10 was used to drive CTB-
Pins expression and the aadA gene was included with a GGAGG
ribosome binding site. The expression cassette was flanked with
SnaB1 recognition sites. The PvuII-digested pLS-LF was treated with
alkaline phosphatase prior to ligation with the SnaB1-digested cas-
sette. The recovered plasmids were digested with SacI to determine
the correct orientation of the inserted cassette in pLS-LF. All cloning
steps were carried out in Escherichia coli according to the methods
of Sambrook and Russel (2001).
Bombardment and selection of transgenic plants
The bombardment and regeneration of N. tabacum cv. Petit Havana
transformants were carried out as described previously (Kumar and
Daniell, 2004).
Seeds of L. sativa v. Simpson elite (New England Seed Co., Hart-
ford, CT, USA) were surface sterilized in a 3% hypochlorite solution,
rinsed three times in water and plated on Murashige and Skoog (MS)
medium solidified with 5.8 g/L Phytablend® (Caisson, North Logan,
UT, USA). Young, fully expanded leaves (~4 cm2) were placed,
adaxial side up, on antibiotic-free LR medium (Kanamoto et al.,
2006). The leaves were bombarded with 0.6-µm gold particles
(Bio-Rad, Hercules, CA, USA) coated with pLS-LF-CTB-Pins (Figure 2a),
as described by Kumar and Daniell (2004), employing 900 psi
rupture discs and a target distance of 6 cm. Samples were held in
the dark at 25 °C for 2 days prior to the explan of 0.5-cm2 pieces,
adaxial side down, on to LR medium containing 50 mg/L spectino-
mycin dihydrochloride. Primary regenerants were screened by PCR
for the transplastomic event, and positive shoots were subjected to
an additional regeneration cycle on LR medium containing spectin-
omycin. Following the second regeneration, the shoots were rooted
in half-strength MS medium containing 0.1 mg/L naphthaleneacetic
acid (NAA) and 50 mg/L spectinomycin. The plants were propagated
by the rooting of nodal sections in half-strength, hormone-free MS
medium containing spectinomycin. Rooted cuttings were hardened
in Jiffy® peat pots before transfer to the glasshouse for seed produc-
tion. T1 seeds (achene) were harvested when the pappus was present,
and allowed to dry at 24 °C. Sterile seeds (100) were plated on MS
medium containing 50 mg/L spectinomycin.
Southern blot analysis
Southern blot analysis was carried out essentially according to Kumar
and Daniell (2004). Total tobacco DNA was digested with AflIII,
separated on a 0.7% agarose gel at 45 V for 4 h, and then trans-
ferred to a nylon membrane. The pUC-CT vector DNA was digested
with BamHI and BglII to generate a 0.8-kb probe, which was used as
a flanking probe, and pLD-CTB-Pins was digested with MfeI and NotI
to generate a 0.36-kb gene-specific probe. After labelling the probe
with 32P, hybridization of the membranes was performed using the
QUICK-HYB hybridization solution and protocol (Stratagene, La Jolla,
CA, USA).
For lettuce transformants, genomic DNA was digested to comple-
tion with BglII, separated on 0.7% Tris-acetate-EDTA (TAE)-agarose
and transferred to nylon membranes. The plastid flanking sequence
probe (1.3 kb) was amplified by PCR from lettuce genomic DNA. The
PCR product was purified, and labelled probe was generated by in-
cubation with 32P and Ready-To-Go™ DNA Labelling Beads (-dCTP)
(GE Healthcare, El Paso, TX, USA). Hybridization was carried out at
68 °C with washing at 37 °C and 60 °C. Radiolabelled blots were
exposed to film at –80 °C for 16 h.
Western blot and densitometric analysis
TSP was isolated from rooted second regenerants of tobacco and
lettuce. TSP from approximately 100 mg of leaf tissue (10 or 20 micro-
grams) was separated by sodium dodecylsulphate-polyacrylamide
gel electrophoresis (SDS-PAGE) and transferred to nitrocellulose
membranes for immunoblotting, according to Kumar and Daniell
(2004). Anti-proinsulin monoclonal antibody (American Qualex,
1 : 20 000, San Clemente, CA, USA) and goat anti-mouse IgG
conjugated to horseradish peroxidase (HRP) (American Qualex,
1 : 15 000) were used for the detection of the CTB-Pins protein.
Immunoblotting with anti-CTB primary antibody (1 : 4000, Sigma,
St. Louis, MO, USA) and HRP-conjugated donkey anti-rabbit
secondary antibody (1 : 12 500, Biomeda, Foster City, CA, USA)
was employed for spot densitometric analysis. For transplastomic
lettuce samples, 36 µg of TSP was added to each well; for transplas-
tomic tobacco samples, 6 µg of TSP was added to each well. The
standards (CTB; Sigma) contained 25, 50 and 100 ng of purified
bacterial CTB. A SuperSignal® West Pico HRP Substrate Kit (Pierce,
Rockford, IL, USA) was used for autoradiographic detection. Follow-
ing exposure to film, the blots were analysed for the presence of
CTB-Pins using AlphaImager® and AlphaEase® FC software (Alpha
Innotech, San Leandro, CA, USA), by comparison with known quan-
tities of standard.
GM1 binding assay
In order to test the ability of chloroplast-derived CTB-Pins to bind to
the GM1 receptor, a CTB–GM1 binding assay was performed. Tobacco
extracts were prepared in ELISA buffer and lettuce extracts were
prepared in western extraction buffer. Ninety-six-well plates were
incubated with monosialoganglioside-GM1 (Sigma) (3.0 µg/mL in
bicarbonate buffer) and bovine serum albumin (BSA) as a control,
and incubated overnight at 4 °C. Following washing [three times
each with 1X phosphate buffered saline with 0.05% (v/v) Tween 20
(PBST) and sterile water], the plate was blocked with 1X PBST (0.1%
Tween 20) with 3% dry, non-fat milk (PTM) (tobacco) or 0.25% BSA
in phosphate-buffered saline (PBS) (lettuce) for 1 h at 37 °C. CTB
standards (Sigma) and soluble protein extracts were diluted in ELISA
plant extraction buffer [without Tween-20 and phenyl methyl
sulphonyl fluoride (PMSF)]. The standards and samples were then
added in duplicate and incubated at 4 °C overnight. Rabbit anti-
CTB primary antibody (1 : 8000 tobacco, 1 : 3000 lettuce; Sigma) and
HRP-conjugated donkey anti-rabbit secondary antibody (1 : 25 000
tobacco and 1 : 12 500 lettuce; Biomeda) were used to detect
the binding of CTB-Pins to the GM1 receptor. The plate was
washed thrice with both PBST and sterile water, and 100 µL of tetra-
methyl benzidine (TMB) soluble solution substrate (American Qualex)
was added to the wells and incubated in the dark for 30 min. The re-
action was stopped with 50 µL of 2 M H2SO4, and read on a plate
reader (Dynex Technologies, Chantilly, VA, USA) at 450 nm.
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Animal studies
Four-week-old, female, NOD mice were purchased from The Jackson
Laboratory (Bar Harbor, ME, USA). Mice were kept in the UCF Wild
Animal Facility under normal light/dark cycle conditions and had
access to food and water ad libitum. The oral administration of
CTB-Pins-expressing transgenic tobacco or control plant leaf material
began when the animals were 5 weeks of age, to allow the mice
1 week to acclimatize to the facility. The mice were divided into
the following groups: group 1 received untransformed plant leaf
material (Un-Tr); group 2 received transgenic plant leaf expressing
CTB conjugated to GFP (CTB-GFP); group 3 received transgenic plant
leaf expressing IFN conjugated to GFP (IFN-GFP); and group 4 received
CTB-Pins-expressing transgenic plant leaf. Each group contained five
animals, except for the CTB-Pins group, which contained seven. The
mice were given 14 µg of the specified ground tobacco leaf material
diluted in 200 µL of PBS (0.1 M) by careful gavage into the hypopharynx
once a week for 7 weeks. For preparation of the gavage material,
leaves were frozen and ground in liquid nitrogen. For oral delivery,
8 mg of the CTB-Pins-expressing plant leaf material contained 14 µg
of the CTB-Pins protein. For the untransformed leaf material, 8 mg
of the ground plant material was given to mimic a similar oral dose
to the CTB-Pins group. The CTB-GFP and IFN-GFP levels were similar
to that of CTB-Pins. The animals were sacrificed at 12 weeks of age,
the pancreas and other tissues were collected, and both blood and
urine glucose levels were measured.
Histochemistry for lymphocytic infiltration and insulitis
Following the 7 weeks of treatment, the mice were sacrificed and
perfused transcardially with 10 mL of PBS, followed by 50 mL of 4%
paraformaldehyde (PFA) in 0.1 M PBS. Part of the pancreas was
saved before fixation and freshly frozen in Tissue Tec freezing
medium (Vector Laboratories, Burlingame, CA, USA). The remaining
pancreas was removed, postfixed overnight in 4% PFA, and cryo-
protected by serially passing through 10%, 20% and 30% sucrose
solutions in PBS. The pancreatic tissue was then immersed in Tissue Tec
freezing medium and frozen (Samsam et al., 2003) in liquid nitrogen-
cooled isomethylbutane (isopathane, Sigma). Frozen sections of the
pancreas, 10 µm thick, were prepared using a cryostat. Pancreas
cryosections were stained with haematoxylin and eosin, dehydrated
in serial graded alcohol solutions, and the slides were covered.
Insulitis levels were measured using the extent of lymphocyte
infiltration of the islets of Langerhans. At least 50 sections per animal
were scored. The degree of insulitis was scored on a scale of 1–5,
where score 1 denotes a normal islet with no sign of T-cell infiltration,
and score 5 indicates maximal infiltration and the development
of insulitis.
Immunohistochemistry for insulin, caspase-3, IL-4 and 
IL-10
Immunohistochemistry for the localization of insulin, caspase-3 (a final
molecule of apoptosis) and the immunosuppressive cytokines IL-4
and IL-10 was performed on pancreas cryosections. Sections were
blocked with 10% BSA containing 0.3% Triton-X100.
Polyclonal guinea pig anti-insulin, polyclonal rabbit anticaspase-
3, and rat monoclonal anti-IL-4 and anti-IL-10 primary antibodies
(Invitrogen) were diluted at a concentration of 1 : 300 in 1% BSA in
PBS containing 0.3% Triton-X. Fluorescent conjugated secondary
antibodies were goat anti-guinea pig Alexa Fluor 488 (green), goat
anti-rabbit Alexa Fluor 555 (red) and goat anti-rat Alexa Fluor 555
(red; Invitrogen).
Antibody titre
Serum and intestinal antibodies were assayed for the presence
of anti-CTB antibodies using colorimetric ELISA methods. Following
sacrifice and prior to transcardial perfusion, 200–300 µL of blood was
collected from the retro-bulbar vein. Serum was extracted after
15 min of centrifugation at 3000 × g at 4 °C for antibody titre. Ninety-
six-well plates were coated with CTB (Sigma). Serial dilutions of
serum or supernatants of faecal pellets (five pellets per sample were
weighed and diluted in 0.1 M PBS), collected from the different animal
groups, were added to the coated plate wells. For standard values
(isotype control) and determination of antibody level, the standard
columns of the plate were coated with serial dilutions of purified
mouse IgG1 or IgG2a, or IgA protein (BD Pharmingen, Franklin
Lakes, NJ, USA), and ELISA was performed. Secondary antibodies
were HRP-conjugated anti-mouse IgG2a, IgG1 and IgA antibodies
(BD Pharmingen) at a concentration of 1 : 3000 in PBS containing
0.1% Tween-20 and 3% milk powder. The plates were washed
with 200 µL of PBS, and the substrate TMB was added to the wells
and incubated in the dark at 37 °C for 20 min. The reaction was
stopped by adding 50 µL of H2SO4, and the plates were read on
a plate reader (Dynex Technologies) at 450 nm.
Blood and urine glucose levels
Blood and urine glucose levels were measured for two consecutive
weeks (11 and 12 weeks of age, or 6 and 7 weeks following the oral
delivery of various plant leaf material). Urine glucose levels were
measured using urinary glucose test strips (Clinistix and Diastix, Bayer,
Wayne, NJ, USA), and blood glucose was measured using a blood
glucose analyser (Boehringer Mannheim, Indianapolis, IN, USA) with
blood obtained from either the tail vein or the retro-bulbar vein (at
week 12, before sacrifice). Blood glucose levels above 250 mg/dL were
considered to be diabetic (Arakawa et al., 1998). The first blood sample
was taken from a small cut on the tail; one drop of blood was placed
on the test strips provided by the manufacturer which were fed to the
glucose analyser. The second blood sample was taken from the retro-
bulbar vein after deep (lethal) inhalation anaesthesia with isoflurane
before transcardial perfusion of 4% PFA. Urine samples were collected
by pressing on the supra-pubic area and squeezing one to two
drops of urine on to the urine strips provided by the manufacturer.
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